Main Management ETF Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$833K Buy
7,330
+120
+2% +$13.6K 0.03% 101
2025
Q1
$758K Buy
+7,210
New +$758K 0.04% 94